Global Fecal Calprotectin Test Market Size To Exceed USD 366.15 Million By 2033 | CAGR of 11.24%
The Global Fecal Calprotectin Test Market Size was Valued at USD 126.15 Million in 2023 and the Worldwide Fecal Calprotectin…
33,970$
Echtzeit-Aktienkurs Meridian Bioscience Inc.
Bid:
Ask:
Nachrichten zur Meridian Bioscience Inc. Aktie
Loop-mediated Isothermal Amplification (LAMP) Market revenue to cross USD 180 Million by 2033, says Research Nester
Major Loop-mediated Isothermal Amplification (LAMP) Market players include Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., New England Biolabs, Inc., Nippon Gene…
Typhoid Antibody Testing Market Size, Outlook: Exploring the 6.55% CAGR and USD 12.36 Billion Projection by 2030
[222 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global…
Global Enteric Disease Testing Market Report to 2027 - Players Include Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience and Quest Diagnostics
DUBLIN, Feb. 2, 2023 /PRNewswire/ -- The "Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast…
Form 8-K MERIDIAN BIOSCIENCE INC For: Jan 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
XFRA : Deletion of Instruments from Boerse Frankfurt - 31.01.2023
The following instruments on Boerse Frankfurt do have their last trading day on 31.01.2023
Die folgenden Instrumente in Boerse Frankfurt haben…
SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience
CINCINNATI and SEOUL, South Korea, Jan. 31, 2023 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of…
XFRA : MR4: Aussetzung/Suspension
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME …
XFRA : INSTRUMENT_SUSPENSION - US5895841014
Instrument ID [10141] (MR4 - US5895841014) suspended...…
DoubleVerify Holdings to Join S&P SmallCap 600
NEW YORK, Jan. 25, 2023 /PRNewswire/ -- DoubleVerify Holdings Inc. (NYSE: DV) will replace Meridian Bioscience Inc. (NASD: VIVO) in…
Meridian Bioscience Shares Up 7.7% on Takeover Set to Close Next Year
Meridian Bioscience Shares Up 7.7% on Takeover Set to Close Next Year...…
Meridian Bioscience gains after announcing Jan. 31 closing date for sale
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger
CINCINNATI, Dec. 12, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and…
Form 8-K MERIDIAN BIOSCIENCE INC For: Dec 12
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Meridian Bioscience (VIVO) Q4 Earnings Surpass Estimates
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do…
Meridian Bioscience Non-GAAP EPS of $0.21, revenue of $65.67M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K MERIDIAN BIOSCIENCE INC For: Nov 22
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K MERIDIAN BIOSCIENCE INC For: Oct 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…